Gnosis' WhitePaper on Adonat now available

Published: 13-Apr-2018

The WhitePaper dedicated to the commercially stable form of S-Adenosyl-L-methionine (SAMe) has been updated with the latest clinical trial results

The One Carbon Metabolism is crucial for people's overall health and well-being. Researchers are particularly interested in how the components of this metabolic pathway influence and affect human health, with particular emphasis on SAMe - the most important human methyl donor - which sustains the cycle activity.

Adonat is involved in more than one hundred biochemical pathways and is important for a variety of functions including detoxification, energy production, immune function, gene maintenance and regulation, mood balancing and inflammation control.

Besides the well known fields of application of SAMe ranging from the mood enhancement to the liver protection and detoxification, new clinical evidence suggests its wider involvement in preventing ageing, and supporting cell and organ longevity, including brain as well as sexual functions and cellular metabolism.

Gnosis has been the first to introduce and commercialise SAMe in the market. With over 30 years of experience, Gnosis is a specialist manufacturer of SAMe using a selected highly productive yeast and fermentation technologies, under the brand name of Adonat. The range includes bulk powder, enteric coated tablets and stabilised oral dosage forms for pharmaceutical, nutritional and veterinary applications.

Adonat includes the following features:

  • studied and proven effective nutritional compound produced by Gnosis to support mood, joint, liver health, antiageing and longevity
  • superior quality with the highest content of the biological active form, the (S,S) active diastereoisomer and the longest available shelf-life in the market.

Request a copy of the WhitePaper at

You may also like